Nova Scotia Prescription Monitoring Program – January 2013 Bulletin Jan 31, 2013 | Communication Points Download now ← Health Canada Endorsed Safety Information on Pradax and Plavix IFHP Temporary Measures Bulletin FINAL_FR v2 →